Topic: How To Invest

What is Pat’s commentary for the week of July 11, 2023

Article Excerpt

Alcon shares let you benefit from the rapidly growing contact lenses and cataract surgery markets. The company’s technological leadership is also set to pay off for investors. Alcon is a spinoff, with Novartis setting it up as a separate company in early 2019. As we’ve said many times, spinoffs are the closest thing you can find to a sure thing, regardless of market ups and downs. In fact, study after study has shown that following an initial adjustment period, spinoffs tend to outperform comparable stocks for several years. Overall, we think Alcon offers investors two ways to profit. Not only does this spinoff provide exposure to rapidly expanding, worldwide demand for its products, but its global operations and research leadership enhance the possibility of a lucrative takeover bid. That interest could come from a rival or a global health-care giant. Our Successful Investor research team has drawn up this Inner Circle Spotlight report on Alcon to explain why we think the stock will…